Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $11.44 billion. The enterprise value is $14.61 billion.
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025, after market close.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 93.05 million shares outstanding. The number of shares has decreased by -8.41% in one year.
| Current Share Class | 93.05M |
| Shares Outstanding | 93.05M |
| Shares Change (YoY) | -8.41% |
| Shares Change (QoQ) | -2.65% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 64.86% |
| Float | 91.22M |
Valuation Ratios
The trailing PE ratio is 14.21 and the forward PE ratio is 5.25. JAZZ's PEG ratio is 0.55.
| PE Ratio | 14.21 |
| Forward PE | 5.25 |
| PS Ratio | 1.87 |
| Forward PS | 2.63 |
| PB Ratio | 1.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.42 |
| P/OCF Ratio | 8.19 |
| PEG Ratio | 0.55 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.60, with an EV/FCF ratio of 10.76.
| EV / Earnings | 26.08 |
| EV / Sales | 3.59 |
| EV / EBITDA | 9.60 |
| EV / EBIT | 16.96 |
| EV / FCF | 10.76 |
Financial Position
The company has a current ratio of 4.46, with a Debt / Equity ratio of 1.51.
| Current Ratio | 4.46 |
| Quick Ratio | 3.57 |
| Debt / Equity | 1.51 |
| Debt / EBITDA | 3.97 |
| Debt / FCF | 4.54 |
| Interest Coverage | 2.50 |
Financial Efficiency
Return on equity (ROE) is 14.31% and return on invested capital (ROIC) is 5.44%.
| Return on Equity (ROE) | 14.31% |
| Return on Assets (ROA) | 4.60% |
| Return on Invested Capital (ROIC) | 5.44% |
| Return on Capital Employed (ROCE) | 7.85% |
| Revenue Per Employee | $1.45M |
| Profits Per Employee | $200,043 |
| Employee Count | 2,800 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.58 |
Taxes
| Income Tax | -91.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.00% in the last 52 weeks. The beta is 0.44, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +2.00% |
| 50-Day Moving Average | 132.07 |
| 200-Day Moving Average | 118.44 |
| Relative Strength Index (RSI) | 32.69 |
| Average Volume (20 Days) | 1,275,794 |
Short Selling Information
The latest short interest is 4.52 million, so 4.86% of the outstanding shares have been sold short.
| Short Interest | 4.52M |
| Short Previous Month | 4.36M |
| Short % of Shares Out | 4.86% |
| Short % of Float | 4.96% |
| Short Ratio (days to cover) | 4.31 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.07 billion and earned $560.12 million in profits. Earnings per share was $8.65.
| Revenue | 4.07B |
| Gross Profit | 3.76B |
| Operating Income | 861.64M |
| Pretax Income | n/a |
| Net Income | 560.12M |
| EBITDA | 1.52B |
| EBIT | 861.64M |
| Earnings Per Share (EPS) | $8.65 |
Full Income StatementBalance Sheet
The company has $2.99 billion in cash and $6.17 billion in debt, giving a net cash position of -$3.17 billion or -$34.10 per share.
| Cash & Cash Equivalents | 2.99B |
| Total Debt | 6.17B |
| Net Cash | -3.17B |
| Net Cash Per Share | -$34.10 |
| Equity (Book Value) | 4.09B |
| Book Value Per Share | 67.52 |
| Working Capital | 3.59B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.40 billion and capital expenditures -$38.07 million, giving a free cash flow of $1.36 billion.
| Operating Cash Flow | 1.40B |
| Capital Expenditures | -38.07M |
| Free Cash Flow | 1.36B |
| FCF Per Share | $14.59 |
Full Cash Flow StatementMargins
Gross margin is 92.36%, with operating and profit margins of 21.18% and 13.77%.
| Gross Margin | 92.36% |
| Operating Margin | 21.18% |
| Pretax Margin | 11.52% |
| Profit Margin | 13.77% |
| EBITDA Margin | 37.40% |
| EBIT Margin | 21.18% |
| FCF Margin | 33.37% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.41% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.90% |
| FCF Yield | 11.87% |
Dividend DetailsAnalyst Forecast
The average price target for JAZZ is $187.15, which is 52.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $187.15 |
| Price Target Difference | 52.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 5.69% |
| EPS Growth Forecast (5Y) | 26.98% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.61 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.61 |
| Piotroski F-Score | 6 |